Clorox’s (CLX) “Hold” Rating Reaffirmed at Jefferies Group
Clorox (NYSE:CLX)‘s stock had its “hold” rating reiterated by Jefferies Group in a report released on Thursday. They currently have a $148.00 target price on the stock. Jefferies Group’s price target points to a potential upside of 1.59% from the stock’s current price.
A number of other research analysts have also weighed in on CLX. Wells Fargo & Co raised their price objective on Clorox from $130.00 to $146.00 and gave the company a “market perform” rating in a report on Thursday. Bank of America upgraded Clorox from an “underperform” rating to a “neutral” rating and set a $155.00 price objective on the stock in a report on Thursday. Zacks Investment Research lowered Clorox from a “hold” rating to a “sell” rating in a report on Wednesday, October 4th. BMO Capital Markets restated a “buy” rating and issued a $150.00 price objective on shares of Clorox in a report on Thursday, October 5th. Finally, Consumer Edge upgraded Clorox from a “neutral” rating to an “outperform” rating in a report on Friday, November 10th. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and three have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $133.33.
Shares of Clorox (NYSE CLX) traded up $2.26 during trading hours on Thursday, hitting $145.69. The stock had a trading volume of 766,882 shares, compared to its average volume of 950,650. Clorox has a 52-week low of $118.41 and a 52-week high of $150.40. The stock has a market cap of $18,790.00, a price-to-earnings ratio of 26.73, a price-to-earnings-growth ratio of 3.94 and a beta of 0.42. The company has a quick ratio of 0.77, a current ratio of 1.10 and a debt-to-equity ratio of 3.02.
In other Clorox news, SVP Michael R. Costello sold 10,574 shares of the firm’s stock in a transaction on Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total value of $1,438,169.74. Following the completion of the sale, the senior vice president now directly owns 34,867 shares of the company’s stock, valued at approximately $4,742,260.67. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Matthew T. Laszlo sold 20,051 shares of the firm’s stock in a transaction dated Wednesday, November 8th. The stock was sold at an average price of $130.46, for a total value of $2,615,853.46. Following the sale, the senior vice president now directly owns 10,896 shares of the company’s stock, valued at $1,421,492.16. The disclosure for this sale can be found here. 1.00% of the stock is owned by company insiders.
Large investors have recently modified their holdings of the stock. Sun Life Financial INC increased its position in shares of Clorox by 10,344.4% during the 2nd quarter. Sun Life Financial INC now owns 940 shares of the company’s stock worth $125,000 after purchasing an additional 931 shares during the last quarter. Acrospire Investment Management LLC acquired a new stake in shares of Clorox during the 2nd quarter worth about $133,000. Salem Investment Counselors Inc. increased its position in shares of Clorox by 2.5% during the 2nd quarter. Salem Investment Counselors Inc. now owns 1,256 shares of the company’s stock worth $167,000 after purchasing an additional 31 shares during the last quarter. Phocas Financial Corp. acquired a new stake in shares of Clorox during the 2nd quarter worth about $167,000. Finally, Jacobi Capital Management LLC increased its position in shares of Clorox by 0.3% during the 2nd quarter. Jacobi Capital Management LLC now owns 1,286 shares of the company’s stock worth $172,000 after purchasing an additional 4 shares during the last quarter. 73.14% of the stock is owned by hedge funds and other institutional investors.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.